
    
      This is a non-randomized trial for patients with previously treated Non-small cell lung
      cancer. Each patient will receive 6 cycles of chemotherapy consisting of Oxaliplatin and
      Navelbine. Oxaliplatin is given intravenously every 21 days and Navelbine is administered
      Intravenously on day 1 and day 8 every 21 days.
    
  